Medtech Insight is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

User Fee Submission Process To Be Explained In Upcoming FR Notice

This article was originally published in The Gray Sheet

Executive Summary

FDA will likely publish a Federal Register notice after the Nov. 5 elections detailing the steps companies must take to submit device user fees, the agency says

You may also be interested in...



MDUFMA 101: Pay User Fees First, Recoup Overpayments Later, FDA Counsels

Manufacturers that have yet to qualify as a "small business" under MDUFMA should pay the full premarket submission user fee amount until FDA grants small company status, the agency is advising

MDUFMA 101: Pay User Fees First, Recoup Overpayments Later, FDA Counsels

Manufacturers that have yet to qualify as a "small business" under MDUFMA should pay the full premarket submission user fee amount until FDA grants small company status, the agency is advising

IVD National Fee Schedule, MDUFMA Oversight Among AdvaMed 2003 Goals

Securing adequate Medicare payment for in vitro diagnostics is one of several legislative priorities for AdvaMed in 2003

Related Content

UsernamePublicRestriction

Register

MT017422

Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel